GMV 0.00% 3.9¢ g medical innovations holdings limited

GMVD - NASDAQ IPO, page-1215

  1. 8,831 Posts.
    lightbulb Created with Sketch. 1048
    In the F1,
    Half way down Page 5 ,

    Preliminary Results for the Year Ended December 31, 2020

    Our estimated, unaudited revenue for the year ended December 31, 2020, was approximately $4.9 million compared to $5.5 for the year ended December 31, 2019, primarily due to the impact of COVID-19 on our businesses.​

    The above estimated financial results are preliminary, based upon our estimates and subject to completion of financial and operating closing procedures for the year ended December 31, 2020. They also represent only a summary of our financial results for such period and are not a comprehensive statement of such results. Final results reflected in our unaudited condensed consolidated financial statements as of and for the year ended December 31, 2020 may differ materially from our estimated results, including as a result of the year-end closing procedures, audit adjustments and other related developments that may arise between now and the time our financial results for the year ended December 31, 2020 are finalized. Our independent registered public accounting firm has not audited, reviewed or performed any procedures with respect to these preliminary results and, accordingly, does not express an opinion or any other form of assurance with respect to these estimates. In addition, these estimates as of and for the year ended December 31, 2020, are not necessarily indicative of the results to be achieved for any future period.​
 
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.